A detailed history of Vivo Capital, LLC transactions in Geron Corp stock. As of the latest transaction made, Vivo Capital, LLC holds 27,225,292 shares of GERN stock, worth $90.9 Million. This represents 18.09% of its overall portfolio holdings.

Number of Shares
27,225,292
Previous 27,225,292 -0.0%
Holding current value
$90.9 Million
Previous $115 Million 7.07%
% of portfolio
18.09%
Previous 17.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$1.75 - $3.44 $5.39 Million - $10.6 Million
3,081,611 Added 12.76%
27,225,292 $89.8 Million
Q4 2023

Feb 06, 2024

BUY
$1.74 - $2.31 $13.3 Million - $17.6 Million
7,619,047 Added 46.11%
24,143,681 $50.9 Million
Q2 2023

Aug 14, 2023

SELL
$1.97 - $3.69 $5.43 Million - $10.2 Million
-2,758,200 Reduced 14.3%
16,524,634 $53 Million
Q4 2022

Feb 13, 2023

BUY
$2.03 - $2.42 $8.21 Million - $9.79 Million
4,044,739 Added 26.54%
19,282,834 $46.7 Million
Q1 2022

May 13, 2022

BUY
$0.99 - $1.6 $15.1 Million - $24.4 Million
15,238,095 New
15,238,095 $20.7 Million

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.26B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.